November 24, 2025

DexCom, Inc. (DXCM) Investor Outlook: A 41% Potential Upside Amid Innovative Diabetes Solutions

DexCom, Inc. (NASDAQ: DXCM), a prominent player in the medical devices sector, has established itself as a leader in continuous glucose monitoring (CGM) systems, catering to the needs of diabetes..

Investor Outlook: The Cooper Companies, Inc. (COO) Eyes Nearly 10% Upside Potential

The Cooper Companies, Inc. (NYSE: COO), a significant player in the healthcare sector, particularly in medical instruments and supplies, presents a compelling opportunity for investors eyeing the healthcare market. With..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: A Look at Potential Upside and Strong Revenue Growth

Dr. Reddy’s Laboratories Ltd (NYSE: RDY) stands as a formidable player in the healthcare sector, specializing in both specialty and generic drug manufacturing. With its headquarters in Hyderabad, India, Dr...

Boston Scientific Corporation (BSX) Investor Outlook: Evaluating a 30% Upside Potential Amidst Strong Buy Ratings

Boston Scientific Corporation (NYSE: BSX) stands as a formidable player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $143.62 billion, the company has..

Quest Diagnostics (DGX) Stock Analysis: Navigating the Strong Revenue Growth and Strategic Market Position

Quest Diagnostics Incorporated (NYSE: DGX) stands as a robust player within the healthcare sector, specifically in the diagnostics and research industry. With a significant market capitalization of $21.39 billion, Quest..

Align Technology, Inc. (ALGN) Stock Analysis: Navigating a 26.61% Potential Upside Amidst Market Challenges

Align Technology, Inc. (NASDAQ: ALGN) is a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. Known for its innovative Invisalign clear aligners and iTero..

Cardinal Health, Inc. (CAH) Stock Analysis: Evaluating Growth Prospects and Performance in the Healthcare Sector

Cardinal Health, Inc. (NYSE: CAH), a prominent player in the healthcare sector, has been capturing investor attention with its robust market presence and strategic initiatives. With a market capitalization of..

BeOne Medicines Ltd. (ONC) Stock Analysis: Unveiling a 14.61% Upside Potential in the Biotech Sector

For investors seeking opportunities in the biotechnology sector, BeOne Medicines Ltd. (ONC) presents an intriguing prospect. Based in Switzerland, this oncology-focused biopharmaceutical company is making waves with its innovative cancer..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Uncovering a Potential 11.65% Upside in the Medical Devices Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a prominent player in the medical devices industry, presents an intriguing opportunity for investors seeking exposure to the healthcare sector. With a market capitalization..

Agilent Technologies, Inc. (A) Stock Analysis: A Healthcare Giant with a Promising Target Price

Agilent Technologies, Inc. (NYSE: A), a powerhouse in the healthcare sector’s diagnostics and research industry, continues to capture investor attention with its strong market presence and promising financial metrics. With..

Koninklijke Philips N.V. (PHG) Stock Analysis: A 24% Potential Upside with Strong Buy Ratings

Koninklijke Philips N.V. (NYSE: PHG), a prominent player in the healthcare sector, is capturing investor attention with its promising potential upside of 24.08%. As a global leader in medical devices,..

Haleon plc (HLN) Stock Analysis: Unpacking a 16.80% Potential Upside

Haleon plc (HLN), a prominent player in the healthcare sector, stands out with its diverse portfolio of consumer healthcare products. As a key figure in the drug manufacturing industry, specializing..

Abbott Laboratories (ABT) Stock Analysis: Strong Buy Ratings and a 13% Upside Potential

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to capture investor interest with its robust market position and promising growth prospects. With a market capitalization of $222.97..

Zoetis Inc. (ZTS) Stock Analysis: Exploring a 39% Potential Upside in the Animal Health Sector

Zoetis Inc. (NYSE: ZTS), a prominent player in the healthcare sector, stands out as a leading drug manufacturer specializing in both specialty and generic animal health products. With a market..

Eli Lilly (LLY) Investor Outlook: A Healthcare Giant with Impressive Revenue Growth and Robust Analyst Confidence

Eli Lilly and Company (NYSE: LLY) stands as a formidable player in the healthcare sector, specifically within the drug manufacturing industry. With a staggering market capitalization of nearly $950 billion,..

Gilead Sciences, Inc. (GILD) Stock Analysis: Exploring a 3.31% Potential Upside Amid Robust Drug Portfolio

Gilead Sciences, Inc. (NASDAQ: GILD), a powerhouse in the biopharmaceutical sector, is currently trading at $126.64, with its stock price change sitting at a modest 0.01% increase. The company’s market..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A 10% Upside Potential in the Healthcare Sector

IQVIA Holdings, Inc. (NYSE: IQV) stands out in the healthcare industry with a market capitalization of $38.3 billion, positioning itself as a key player in the diagnostics and research sector...

Pfizer, Inc. (PFE) Investor Outlook: Analyzing a Promising 15.64% Potential Upside

Pfizer Inc. (NYSE: PFE), a stalwart in the healthcare sector, offers a compelling narrative for investors seeking stability combined with growth potential. With a market capitalization of $142.37 billion, Pfizer..

Veeva Systems Inc. (VEEV) Stock Analysis: Navigating a 29.78% Potential Upside in the Healthcare Software Sector

Veeva Systems Inc. (NYSE: VEEV), a leading provider of cloud-based solutions for the life sciences industry, presents a compelling investment opportunity with a notable potential upside of 29.78%. With a..

CVS Health Corporation (CVS) Stock Analysis: Evaluating a 17.24% Potential Upside Amid Strong Buy Ratings

CVS Health Corporation (NYSE: CVS) stands as a formidable player in the healthcare sector, a segment increasingly critical in today’s evolving market landscape. With a robust market capitalization of $99.05..

Search

Funds

November 24, 2025

Search

Funds

November 24, 2025

FTSE 100

Funds